Can Red Cell Exchange Treat Advanced Sickle Cell Disease?
PITTSBURGH – Medical advances have dramatically increased the life expectancy of patients with sickle cell disease, but as patients are living longer, they are increasingly experiencing organ damage leading to early death. Now, researchers at the University of Pittsburgh and UPMC, supported by a $19.2 million National Institutes of Health grant, will lead the largest clinical trial of its kind to test a technique called red cell exchange transfusion in prolonging life and slowing or reversing organ damage. READ MORE
NEW: Patients with sickle cell disease die early because of organ damage. @PittTweet and UPMC are leading a $19.2M @NIH-funded international clinical trial to find out if a technique called red cell exchange could help prolong life for these patients. https://t.co/ZYz7FmJ9r5 pic.twitter.com/GjCeRL1t4K— UPMC (@UPMCnews) July 9, 2019